Metropolitan Life Insurance Company (MetLife)’s Amkor Technology AMKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,918
| Closed | -$191K | – | 120 |
|
|
2024
Q1 | $191K | Sell |
5,918
-474
| -7% | -$15K | 0.01% | 736 |
|
|
2023
Q4 | $213K | Buy |
6,392
+517
| +9% | +$13.6K | 0.01% | 706 |
|
|
2023
Q3 | $133K | Buy |
5,875
+243
| +4% | +$6.41K | 0.01% | 873 |
|
|
2023
Q2 | $168K | Hold |
5,632
| – | – | 0.01% | 755 |
|
|
2023
Q1 | $147K | Sell |
5,632
-643
| -10% | -$17.6K | 0.01% | 797 |
|
|
2022
Q4 | $150K | Buy |
6,275
+145
| +2% | +$3.36K | 0.01% | 845 |
|
|
2022
Q3 | $105K | Hold |
6,130
| – | – | 0.01% | 990 |
|
|
2022
Q2 | $104K | Hold |
6,130
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q1 | $133K | Sell |
6,130
-35,962
| -85% | -$814K | ﹤0.01% | 1023 |
|
|
2021
Q4 | $1.04M | Sell |
42,092
-1,092
| -3% | -$25.4K | 0.01% | 929 |
|
|
2021
Q3 | $1.08M | Sell |
43,184
-3,787
| -8% | -$96.6K | 0.02% | 897 |
|
|
2021
Q2 | $1.11M | Buy |
46,971
+2,112
| +5% | +$47K | 0.02% | 928 |
|
|
2021
Q1 | $1.06M | Buy |
44,859
+17,408
| +63% | +$356K | 0.02% | 900 |
|
|
2020
Q4 | $414K | Sell |
27,451
-1,534
| -5% | -$20.9K | 0.01% | 1481 |
|
|
2020
Q3 | $325K | Sell |
28,985
-884
| -3% | -$10.9K | 0.01% | 1493 |
|
|
2020
Q2 | $368K | Buy |
29,869
+4,049
| +16% | +$41.8K | 0.01% | 1427 |
|
|
2020
Q1 | $201K | Sell |
25,820
-3,963
| -13% | -$43.1K | ﹤0.01% | 1585 |
|
|
2019
Q4 | $387K | Sell |
29,783
-1,104
| -4% | -$13.2K | 0.01% | 1487 |
|
|
2019
Q3 | $281K | Hold |
30,887
| – | – | ﹤0.01% | 1648 |
|
|
2019
Q2 | $230K | Buy |
30,887
+1,589
| +5% | +$12.4K | ﹤0.01% | 1809 |
|
|
2019
Q1 | $250K | Sell |
29,298
-1,773
| -6% | -$14.7K | ﹤0.01% | 1754 |
|
|
2018
Q4 | $204K | Hold |
31,071
| – | – | ﹤0.01% | 1811 |
|
|
2018
Q3 | $230K | Hold |
31,071
| – | – | ﹤0.01% | 1907 |
|
|
2018
Q2 | $267K | Hold |
31,071
| – | – | ﹤0.01% | 1749 |
|
|
2018
Q1 | $315K | Buy |
31,071
+1,989
| +7% | +$20.7K | ﹤0.01% | 1581 |
|
|
2017
Q4 | $292K | Sell |
29,082
-106,020
| -78% | -$1.13M | ﹤0.01% | 1637 |
|
|
2017
Q3 | $1.43M | Buy |
135,102
+67,254
| +99% | +$644K | 0.01% | 1065 |
|
|
2017
Q2 | $663K | Hold |
67,848
| – | – | ﹤0.01% | 1490 |
|
|
2017
Q1 | $786K | Buy |
67,848
+1,881
| +3% | +$19.4K | 0.01% | 1360 |
|
|
2016
Q4 | $696K | Sell |
65,967
-2,661
| -4% | -$28.3K | 0.01% | 1529 |
|
|
2016
Q3 | $667K | Sell |
68,628
-10,827
| -14% | -$86.7K | ﹤0.01% | 1526 |
|
|
2016
Q2 | $457K | Hold |
79,455
| – | – | ﹤0.01% | 1756 |
|
|
2016
Q1 | $468K | Buy |
79,455
+133
| +0.2% | +$722 | ﹤0.01% | 1611 |
|
|
2015
Q4 | $482K | Buy |
79,322
+13,745
| +21% | +$83.2K | ﹤0.01% | 1645 |
|
|
2015
Q3 | $294K | Buy |
65,577
+3,261
| +5% | +$16K | ﹤0.01% | 1996 |
|
|
2015
Q2 | $373K | Sell |
62,316
-4,156
| -6% | -$29.9K | ﹤0.01% | 1955 |
|
|
2015
Q1 | $587K | Hold |
66,472
| – | – | ﹤0.01% | 1475 |
|
|
2014
Q4 | $472K | Hold |
66,472
| – | – | ﹤0.01% | 1798 |
|
|
2014
Q3 | $559K | Hold |
66,472
| – | – | ﹤0.01% | 1652 |
|
|
2014
Q2 | $743K | Buy |
66,472
+9,816
| +17% | +$90.6K | 0.01% | 1549 |
|
|
2014
Q1 | $389K | Sell |
56,656
-6,382
| -10% | -$37.3K | ﹤0.01% | 1981 |
|
|
2013
Q4 | $386K | Buy |
63,038
+9,156
| +17% | +$48.8K | ﹤0.01% | 1992 |
|
|
2013
Q3 | $231K | Hold |
53,882
| – | – | ﹤0.01% | 2313 |
|
|
2013
Q2 | $227K | Buy |
+53,882
| New | +$227K | ﹤0.01% | 2258 |
|
Other funds holding AMKR
Metropolitan Life Insurance Company (MetLife)'s AMKR Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Amkor Technology (AMKR) in Q2 2024, closing a stake of 5,918 shares — an estimated $191K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in AMKR in Q2 2013 and held it in 44 quarters. The position peaked at $1.43M in Q3 2017. 395 funds tracked by Wall St. Rank hold AMKR as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Amkor Technology position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 5,918 Amkor Technology shares in Q2 2024, an estimated $191K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Amkor Technology in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Amkor Technology position peaked at $1.43M in Q3 2017.
- 395 funds tracked by Wall St. Rank held Amkor Technology as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.